A Prospective, Multi-center, Open-labeled, Randomized Clinical Trial of Patient Adherence and Convenience to Immunosuppressive Agents in Newly Liver Transplant Recipients to Compare QD Early Conversion and BID Tacrolimus Formulation.
Not yet recruiting
Phase of Trial: Phase IV
Latest Information Update: 12 Aug 2017
At a glance
- Drugs Tacrolimus (Primary)
- Indications Liver transplant rejection
- Focus Therapeutic Use
- 07 Aug 2017 Planned initiation date changed from 1 Aug 2017 to 1 Sep 2017.
- 18 Jul 2017 New trial record